Synlogic, Inc. (SYBX)
1.175
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Synlogic Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 1.086 |
| December 31, 2023 | 0.405 |
| September 30, 2023 | 0.4193 |
| June 30, 2023 | 0.351 |
| March 31, 2023 | 0.2809 |
| December 31, 2022 | 0.2457 |
| September 30, 2022 | 0.2026 |
| June 30, 2022 | 0.1815 |
| March 31, 2022 | 0.1635 |
| December 31, 2021 | 0.1398 |
| September 30, 2021 | 0.132 |
| June 30, 2021 | 0.172 |
| March 31, 2021 | 0.2036 |
| December 31, 2020 | 0.1981 |
| September 30, 2020 | 0.1942 |
| June 30, 2020 | 0.1824 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1727 |
| December 31, 2019 | 0.1594 |
| September 30, 2019 | 0.1517 |
| June 30, 2019 | 0.1395 |
| March 31, 2019 | 0.0037 |
| December 31, 2018 | 0.0038 |
| September 30, 2018 | 0.0043 |
| June 30, 2018 | 0.0047 |
| March 31, 2018 | 0.0061 |
| December 31, 2017 | 0.0105 |
| September 30, 2017 | 0.0045 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.0281 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.48M |
| Total Liabilities (Quarterly) | 1.461M |
| Shareholders Equity (Quarterly) | 12.02M |
| Current Ratio | 9.191 |